-
FDA approves BI's Pradaxa
SILVER SPRING, Md. The Food and Drug Administration approved a drug for preventing strokes and blood clots in patients with abnormal heart rhythm, the agency said Tuesday.
The FDA announced the approval of Pradaxa (dabigatran etexilate) capsules, an anticlotting drug made by Boehringer Ingelheim for patients with atrial fibrillation, a type of abnormal heart rhythm that affects more than 2 million Americans.
-
Enactment of new drug-disposal law a victory for pharmacy, NACDS says
WASHINGTON Enactment by the White House of a landmark, pharmacy-friendly drug-disposal bill won quick praise from chain pharmacy leaders Thursday.
President Obama signed the Secure and Responsible Drug Disposal Act into law Wednesday, changing the way the Drug Enforcement Administration regulates the return and destruction of unused and unwanted higher-risk medications. The new law establishes a legal process by which consumers can return their lawfully obtained controlled substance medications to DEA-authorized entities for disposal.